Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Tselios

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Molecules (Basel, Switzerland)|November 7, 2014
Rational design and synthesis of altered peptide ligands based on human myelin oligodendrocyte glycoprotein 35-55 epitope: inhibition of chronic experimental autoimmune encephalomyelitis in miceTheodore Tselios, Mihalis Aggelidakis, Anthi Tapeinou, et al.
Molecular Immunology|June 11, 2008
Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2Maria Katsara, Elizabeth Yuriev, Paul A Ramsland, et al.
Journal of Neuroimmunology|August 5, 2008
A double mutation of MBP(83-99) peptide induces IL-4 responses and antagonizes IFN-gamma responsesMaria Katsara, Elizabeth Yuriev, Paul A Ramsland, et al.
Journal of Medicinal Chemistry|December 17, 2008
Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosisMaria Katsara, George Deraos, Theodore Tselios, et al.
Current Medicinal Chemistry|June 25, 2005
Animal models of central nervous system immune-mediated diseases: therapeutic interventions with bioactive peptides and mimeticsNikolaos Grigoriadis, Theodore Tselios, Spyros Deraos, et al.
European Journal of Medicinal Chemistry|November 7, 2012
Rationally designed cyclic analogues of luteinizing hormone-releasing hormone: enhanced enzymatic stability and biological propertiesDespina Laimou, Theodora Katsila, John Matsoukas, et al.
Analytical Biochemistry|June 17, 2015
Conjugation of a peptide to mannan and its confirmation by tricine sodium dodecyl sulfate-polyacrylamide gel electrophoresisAnthi Tapeinou, Maria-Eleni Androutsou, Konstantina Kyrtata, et al.
Brain Sciences|July 8, 2017
Multiple Sclerosis: Immunopathology and Treatment UpdateNarges Dargahi, Maria Katsara, Theodore Tselios, et al.
Amino Acids|July 8, 2010
Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluationGeorge Agelis, Amalia Resvani, Minos-Timotheos Matsoukas, et al.
Frontiers in Immunology|June 18, 2015
Mannosylated Linear and Cyclic Single Amino Acid Mutant Peptides Using a Small 10 Amino Acid Linker Constitute Promising Candidates Against Multiple SclerosisStephanie Day, Theodore Tselios, Maria-Eleni Androutsou, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Molecules (Basel, Switzerland)|November 7, 2014
Rational design and synthesis of altered peptide ligands based on human myelin oligodendrocyte glycoprotein 35-55 epitope: inhibition of chronic experimental autoimmune encephalomyelitis in miceTheodore Tselios, Mihalis Aggelidakis, Anthi Tapeinou, et al.
Molecular Immunology|June 11, 2008
Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2Maria Katsara, Elizabeth Yuriev, Paul A Ramsland, et al.
Journal of Neuroimmunology|August 5, 2008
A double mutation of MBP(83-99) peptide induces IL-4 responses and antagonizes IFN-gamma responsesMaria Katsara, Elizabeth Yuriev, Paul A Ramsland, et al.
Journal of Medicinal Chemistry|December 17, 2008
Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosisMaria Katsara, George Deraos, Theodore Tselios, et al.
Current Medicinal Chemistry|June 25, 2005
Animal models of central nervous system immune-mediated diseases: therapeutic interventions with bioactive peptides and mimeticsNikolaos Grigoriadis, Theodore Tselios, Spyros Deraos, et al.
European Journal of Medicinal Chemistry|November 7, 2012
Rationally designed cyclic analogues of luteinizing hormone-releasing hormone: enhanced enzymatic stability and biological propertiesDespina Laimou, Theodora Katsila, John Matsoukas, et al.
Analytical Biochemistry|June 17, 2015
Conjugation of a peptide to mannan and its confirmation by tricine sodium dodecyl sulfate-polyacrylamide gel electrophoresisAnthi Tapeinou, Maria-Eleni Androutsou, Konstantina Kyrtata, et al.
Brain Sciences|July 8, 2017
Multiple Sclerosis: Immunopathology and Treatment UpdateNarges Dargahi, Maria Katsara, Theodore Tselios, et al.
Amino Acids|July 8, 2010
Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluationGeorge Agelis, Amalia Resvani, Minos-Timotheos Matsoukas, et al.
Frontiers in Immunology|June 18, 2015
Mannosylated Linear and Cyclic Single Amino Acid Mutant Peptides Using a Small 10 Amino Acid Linker Constitute Promising Candidates Against Multiple SclerosisStephanie Day, Theodore Tselios, Maria-Eleni Androutsou, et al.
Pageof 7